Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2017 at "Fertility and sterility"
DOI: 10.1016/j.fertnstert.2017.07.1165
Abstract: OBJECTIVE To investigate the efficacy and safety of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen (FlexibleMIB) compared with placebo to treat endometriosis-associated pelvic pain (EAPP). DESIGN A phase 3, randomized, double-blind, placebo-controlled, parallel-group study,… read more here.
Keywords: endometriosis; phase; endometriosis associated; ethinylestradiol drospirenone ... See more keywords
Inconsistencies in laboratory investigations of hypertension in a young woman taking ethinylestradiol/drospirenone association.
Sign Up to like & getrecommendations! Published in 2022 at "Acta clinica Belgica"
DOI: 10.1080/17843286.2022.2132764
Abstract: CASE PRESENTATION A 34-year-old woman presented to the emergency department for arterial hypertension. Blood analysis requested by the endocrinologist showed very high level of aldosterone (1805 ng/L, normal values: read more here.
Keywords: drospirenone; renin; ethinylestradiol drospirenone; drospirenone association ... See more keywords